Jessica E. Malberg

Neuroscience · Life Sciences

26h-index9.3kcitations37works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenesis and neuroplasticity mechanisms(17), Neuroscience and Neuropharmacology Research(10), Neurotransmitter Receptor Influence on Behavior(9), Nerve injury and regeneration(8), Nuclear Receptors and Signaling(6)

Publications37 total

Phase 1b study of XPro1595 in Alzheimer's patients with biomarkers of inflammation
Alzheimer s & Dementia·2021· 2 cited
Adult Neurogenesis and Antidepressant Treatment: The Surprise Finding by Ron Duman and the Field 20 Years Later
Biological Psychiatry·2021· 38 cited
Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action
Figshare·2020Open Access
A Volumetric Assessment Using Computed Tomography of Canine and First Molar Roots in Dogs of Varying Weight
Journal of Veterinary Dentistry·2018· 10 cited
5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats
The International Journal of Neuropsychopharmacology·2009· 25 cited
Preclinical characterization of WAY‐211612: a dual 5‐HT uptake inhibitor and 5‐HT<sub>1A</sub>receptor antagonist and potential novel antidepressant
British Journal of Pharmacology·2009· 9 citedOpen Access
Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action
Journal of Medicinal Chemistry·2009· 52 citedOpen Access
Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission
European Journal of Pharmacology·2008· 55 citedOpen Access
VGF, a New Player in Antidepressant Action?
Science Signaling·2008· 29 citedOpen Access
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments
Brain Research·2008· 193 citedOpen Access
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Psychopharmacology·2008· 139 cited
cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response
Journal of Neuroscience·2007· 101 citedOpen Access
Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects
Neuropsychopharmacology·2007· 95 cited
Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase system
Journal of Neuroscience Research·2007· 14 cited
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents
Psychopharmacology·2007· 100 cited
Differentiating antidepressants of the future: Efficacy and safety
Pharmacology & Therapeutics·2006· 174 cited
In Vitro and In Vivo Pharmacological Characterization of Galanin and Galnon
The FASEB Journal·2006
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications
Psychopharmacology·2006· 320 cited
P.4.b.002 The central neuropeptide S system: expression, pharmacology and behavioural significance of neuropeptide S receptors
European Neuropsychopharmacology·2006
Antidepressant action: to the nucleus and beyond
Trends in Pharmacological Sciences·2005· 192 cited
page 1 of 2Next →

Frequent Co-authors

Sharon Rosenzweig‐Lipson(12), Lee E. Schechter(11), Ronald S. Duman(7), Irwin Lucki(6), Lewis S. Seiden(6), Robert H. Ring(6), Stacey J. Sukoff Rizzo(5), Shin Nakagawa(4), Chad E. Beyer(4), Brian J. Platt(4), Brian A. Hoshaw(3), Lisa Potestio(3), Zoë A. Hughes(3), Xavier Khawaja(3), Robert Lew(3), Eric J. Nestler(2), Ji‐Eun Kim(2), Rena Lee(2), Jingshan Chen(2), Zia Ur Rahman(2)